Miki Naito

12PUBLICATIONS
20CO-AUTHORS
Solid tumoursPredictive and prognostic markersMolecular targetsPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 08, 2026
Impact of surgical start time on clinical outcomes in urologic surgery: a single-center study of major oncologic surgeries and adrenalectomy.

|Jul 23, 2026
External Validation of Prognostic Models for Nonmetastatic Clear Cell Renal Cell Carcinoma in a Japanese Cohort: Evaluation of Predictive Performance.

|Jul 01, 2026
Clinical and genomic characteristics of primary resistant disease to first-line immuno-oncology plus VEGFR inhibitor therapy in metastatic renal cell carcinoma.

|Apr 22, 2026
Impact of the Nadir Androgen Receptor Signaling Inhibitor-Derived Integrative Response Model in Real-World Patients With Metastatic Castration-Sensitive Prostate Cancer.

|Feb 26, 2026
KIFC1 is Associated With Sarcomatoid Differentiation, Immune Response, and a Poor Prognosis in Clear Cell Renal Cell Carcinoma.

Yoshinori Nakano, Yohei Sekino, Go Kobayashi

|Jan 26, 2026
Genomic and Clinical Impact of Smoking on Therapeutic Outcomes in Prostate Cancer: A Public Databases Analysis.

Tomoya Hatayama, Yohei Sekino, Go Kobayashi

Pageof 2

Frequent Collaborators

11 joint publications

Nobuyuki Hinata

9 joint publications

Kohei Kobatake

9 joint publications

Shunsuke Miyamoto

7 joint publications

Kenshiro Takemoto